No Matches Found
No Matches Found
No Matches Found
Astellas Pharma, Inc.
Astellas Pharma Stock Hits Day Low Amid Price Pressure, Drops to JPY 1,569.00
Astellas Pharma, Inc. saw a significant stock decline today, contrasting with the modest decrease in the Japan Nikkei 225. Over the past year, Astellas has underperformed, with a notable drop compared to the index's gains. Despite challenges, the company shows strong management efficiency metrics.
Astellas Pharma Stock Hits Day Low Amid Price Pressure, Drops 4.6%
Astellas Pharma, Inc. faced a significant stock decline today, contrasting with the broader market's performance. Over the past year, the company has seen a notable drop, despite a substantial increase in profits. Astellas maintains a strong EBIT to Interest ratio, reflecting its debt management capabilities.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

